Drugs join forces to overcome lung cancer resistance
October 30th, 2009
Combining two targeted cancer therapies may overcome the resistance that some lung tumors develop during treatment, according to a recent report in the Journal of Clinical Investigation.
The study, which tested the drug combo in mouse models of lung cancer, supports moving forward with clinical trials in patients with lung cancer.